Abingdon Health Plc (AIM:ABDX)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 50.92M +93.5% |
| Revenue (ttm) | 9.57M +40.4% |
| Net Income | -3.24M |
| EPS | -0.01 |
| Shares Out | 433.39M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 266,374 |
| Open | 11.50 |
| Previous Close | 11.75 |
| Day's Range | 11.00 - 12.00 |
| 52-Week Range | 5.10 - 13.00 |
| Beta | 0.18 |
| Analysts | Strong Buy |
| Price Target | 19.00 (+72.73%) |
| Earnings Date | Jun 22, 2026 |
About Abingdon Health
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is based in York, the United Kingdom. [Read more]
Financial Performance
In fiscal year 2025, Abingdon Health's revenue was 8.43 million, an increase of 37.39% compared to the previous year's 6.14 million. Losses were -3.42 million, 168.7% more than in 2024.
Financial StatementsNews
Abingdon Health plc to Present at the Small Cap Growth Virtual Investor Conference June 4th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as ...